✦ LIBER ✦

Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)

✍ Scribed by Cheryl Lin; Meredith Becker Buxton; Dan Moore; Helen Krontiras; Lisa Carey; Angela DeMichele; Leslie Montgomery; Debasish Tripathy; Constance Lehman; Minetta Liu; Olufunmilayo Olapade; Christina Yau; Donald Berry; Laura J. Esserman; I-SPY TRIAL Investigators

Book ID: 113062282
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 404 KB
Volume: 132
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1670-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Local Recurrence Rates are Low in High-R

Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

✍ Cureton, Elizabeth L.; Yau, Christina; Alvarado, Michael D.; Krontiras, Helen; O 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 331 KB

Pathologic Complete Response Predicts Re

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

✍ Glück, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Chemotherapy response and recurrence-fre

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

✍ Laura J. Esserman; Donald A. Berry; Maggie C. U. Cheang; Christina Yau; Charles 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 788 KB